https://www.selleckchem.com/products/b02.html
In overall population of 90 patients, SBx would have been avoided in 54 (60%). Implementation of TruGraf™ testing in a "real-world" cohort at the time of SBx identified a significant proportion of KTRs that could have avoided SBx. Implementation of TruGraf™ testing in a "real-world" cohort at the time of SBx identified a significant proportion of KTRs that could have avoided SBx.We read with interest the paper "HepatoScore-14 Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk" by Dr. Morri
처럼
논평
공유하다
